Retrovirology.
Publisher:
BioMed Central,
Frequency: Irregular
Country: England
Language: English
Start Year:2004 -
ISSN:
1742-4690 (Electronic)
1742-4690 (Linking)
1742-4690 (Linking)
Impact Factor
3.2
2022
| NLM ID: | 101216893 |
| (OCoLC): | 54798617 |
| LCCN: | 2004243415 |
Genetic Evolution during the development of an attenuated EIAV vaccine. The equine infectious anemia virus (EIAV) vaccine is the only attenuated lentiviral vaccine applied on a large scale that has been shown to be effective in controlling the prevalence of EIA in China. This vaccine was developed by successive passaging of a field-isolated virulent strain in different hosts and cultivated cells. To explore the molecular basis for the phenotype alteration of this vaccine strain, we systematically analyzed its genomic evolution during vaccine development. Results: Sequence analysis revealed that the genetic distance between the wild-type strain and six representati...
Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. The equine infectious anemia virus (EIAV) is a lentivirus of the Retrovirus family, which causes persistent infection in horses often characterized by recurrent episodes of high fever. It has a similar morphology and life cycle to the human immunodeficiency virus (HIV). Its transmembrane glycoprotein, gp45 (analogous to gp41 in HIV), mediates membrane fusion during the infection. However, the post-fusion conformation of EIAV gp45 has not yet been determined. EIAV is the first member of the lentiviruses for which an effective vaccine has been successfully developed. The attenuated vaccine strai...
An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family. Equine infectious anemia virus (EIAV), a lentivirus that infects horses, has been utilized as an animal model for the study of HIV. Furthermore, the disease associated with the equine lentivirus poses a significant challenge to veterinary medicine around the world. As with all lentiviruses, EIAV has been shown to have a high propensity for genomic sequence and antigenic variation, especially in its envelope (Env) proteins. Recent studies have demonstrated Env variation to be a major determinant of vaccine efficacy, emphasizing the importance of defining natural variation among field isolates o...